Fundamental Analyzer

Condenses a full fundamental workup — growth, profitability, economic profit (ROIC vs WACC), dividends and solvency — into a single Health Score, alongside fair-value price lines from P/E, P/S, P/B and dividend models. The Cheap / Fair / Expensive verdict reads the gap between price and those lines against the gap this stock normally carries: a business whose multiple re-rated years ago sits permanently above a median-multiple fair value, and that standing gap is not news.